| Literature DB >> 36042500 |
Wenlong Zheng1, Miao Zhang2, Wenbin Wu2, Hui Zhang2, Xinhui Zhang3.
Abstract
BACKGROUND: Pulmonary sequestration (PS) is a rare lesion with independent blood supply from an anomalous systemic artery. A timely resection is considered as the best treatment for PS. Three-dimensional computed tomography angiography (3D-CTA) has been widely utilized for precise thoracic surgery. This study aimed to investigate the role of preoperative 3D-CTA and resection simulation in uniportal video-assisted thoracoscopic surgery (VATS) anatomical lung surgery for PS.Entities:
Keywords: Bronchopulmonary sequestration (BPS); Pulmonary sequestration (PS); Three-dimensional computed tomography angiography (3D-CTA); Video-assisted thoracoscopic surgery (VATS)
Mesh:
Year: 2022 PMID: 36042500 PMCID: PMC9429313 DOI: 10.1186/s13019-022-01975-8
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.522
Baseline characteristics of the patients with pulmonary sequestration
| Variables | Total (n = 20) | 3D-CTA group (n = 10) | Control group (n = 10) | |
|---|---|---|---|---|
| Age (range), y | 45.0 ± 9.1 (23–60) | 40.6 ± 12.0 (23–60) | 44.7 ± 8.4 (26–55) | 0.389 |
| Female, n (%) | 12 (%) | 6 (60) | 6 (60) | 1.000 |
| Body mass index (range), kg/m2 | 24.6 ± 3.0 (19.6–29.4) | 25.2 ± 3.0 (20.2–29.4) | 23.3 ± 3.1 (19.6–27.7) | 0.181 |
| Major symptoms on admission, n (%) | 0.079 | |||
| Recurrent respiratory tract infection (cough/expectoration/fever) | 5 (25.0) | 4 (40.0) | 1 (10.0) | |
| Hemoptysis | 4 (20.0) | 3 (30.0) | 1 (10.0) | |
| Asymptomatic | 11 (55.0) | 3 (30.0) | 8 (80.0) | |
| Sequestration type, n (%) | 1.000 | |||
| Intralobar | 18 (90.0) | 9 (90.0) | 9 (90.0) | |
| Extralobar | 2 (10.0) | 1 (10.0) | 1 (10.0) | |
| Location of the sequestrated lung, n (%) | 0.136 | |||
| Left lower lobe | 18 (90.0) | 8 (80.0) | 10 (100) | |
| Right lower lobe | 2 (10.0) | 2 (20.0) | 0 | |
| Origin of the aberrant feeding vessels, n (%) | 0.119 | |||
| Thoracic aorta | 16 (80.0) | 7 (70.0) | 9 (90.0) | |
| Abdominal aorta | 3 (15.0) | 3 (30.0) | 0 | |
| Inferior phrenic artery | 1 (5.0) | 0 | 1 (10.0) | |
| Venous drainage of the sequestrated lung, n (%) | 0.361 | |||
| Pulmonary veins | 8 (40.0) | 3 (30.0) | 5 (50.0) | |
| Undetermined | 12 (60.0) | 7 (70.0) | 5 (50.0) | |
| Preoperative FEV1 (range), L | 3.0 ± 0.5 (1.8–3.8) | 2.9 ± 0.6 (1.9–3.6) | 2.9 ± 0.6 (1.8–3.8) | 0.856 |
3D-CTA three-dimensional computed tomographic angiography, FEV1 forced expiratory volume in one second
Perioperative data of the patients
| Variables | Total (n = 20) | 3D-CTA group (n = 10) | Control group (n = 10) | |
|---|---|---|---|---|
| Extensive pleural adhesion, n (%) | 5 (25.0) | 3 (30.0) | 2 (20.0) | 0.605 |
| Surgical procedures, n (%) | 0.144 | |||
| Lobectomy | 13 (65.0) | 6 (60.0) | 7 (70.0) | |
| Segmentectomy | 5 (25.0) | 4 (40.0) | 1 (10.0) | |
| Mass resection | 2 (10.0) | 0 | 2 (20.0) | |
| Initial surgical planning, n (%) | < 0.001* | |||
| Uniportal VATS | 9 (45.0) | 9 (90) | 0 | |
| Two-port VATS | 11 (55.0) | 1 (10) | 10 (100) | |
| Conversion of the surgical approach, n (%) | 6 (30.0) | 0 | 6 (60.0) | 0.003* |
| Three-port VATS | 4 (20.0) | 0 | 4 (40.0) | |
| Thoracotomy | 2 (10.0) | 0 | 2 (20.0) | |
| Disconnection of aberrant vessels, n (%) | 0.531 | |||
| Endo-stapler | 17 (85.0) | 9 (90.0) | 8 (80.0) | |
| Ligation using silk | 3 (15.0) | 1 (10.0) | 2 (20.0) | |
| Mean operation time (range), min | 131.5 ± 39.8 (75–220) | 108.5 ± 24.9 (75–150) | 154.5 ± 39.4 (100–220) | 0.006* |
| Estimated blood loss (range), mL | 92.5 ± 40.6 (50–200) | 85.0 ± 41.2 (50–150) | 100.0 ± 40.8 (50–200) | 0.424 |
| Postoperative complications, n (%) | 4 (20.0) | 1 (10.0) | 3 (30.0) | 0.264 |
| Pulmonary infection | 1 (5.0) | 0 | 1 (10.0) | |
| Prolonged air leakage (> 5 days) | 1 (5.0) | 1 (10.0) | 0 | |
| Chylothorax | 1 (5.0) | 0 | 1 (10.0) | |
| Bronchopleural fistula | 1 (5.0) | 0 | 1 (10.0) | |
| Duration of the chest tube (range), d | 6.8 ± 2.8 (3–15) | 7.8 ± 3.4 (3–13) | 7.2 ± 3.3 (4–15) | 0.485 |
| Total thorax drainage volume (range), mL | 1233.8 ± 771.8 (350–3150) | 926.0 ± 450.0 (350–1850) | 1541.5 ± 918.9 (550–3150) | 0.073 |
| Postoperative hospital stay (range), d | 8.9 ± 3.9 (4–19) | 8.0 ± 3.5 (4–16) | 9.6 ± 4.2 (5–19) | 0.312 |
| Pathological diagnosis, n (%) | 0.315 | |||
| PS | 19 (95.0) | 9 (90.0) | 10 (100) | |
| Carcinoma within the PS | 1 (5.0) | 1 (10.0) | 0 | |
| 30-days mortality | 0 | 0 | 0 | – |
| Follow up (range), month | 35.3 ± 19.0 (5–75) | 32.6 ± 20.2 (5–75) | 38.0 ± 18.3 (12–70) | 0.539 |
| Recurrence of cough or hemoptysis | 0 | 0 | 0 | – |
3D-CTA three-dimensional computed tomographic angiography, VATS video-assisted thoracoscopic surgery, PS pulmonary sequestration
*P < 0.05
Fig. 1The sequestrated lung located in the right lower lobe was diagnosed using conventional two-dimensional computed tomography. A The lesion mimics bronchiectasis and infection; B contrast-enhanced images revealed the aberrant feeding vessel
Fig. 2Three-dimensional computed tomography angiography showed definitely the anomalous blood supply. A A mass was located in the left lower lobe; B the abnormal feeding artery was next to the spleen artery; C the feeding artery originated from the abdominal aorta was finally confirmed
Previous reports of thoracoscopic lung surgery for adult patients with pulmonary sequestration
| First author, year | No. of patients | Age, y | ILS/ELS, n | Location: left/right thorax, n | Origin of the feeding: thoracic/abdominal aorta, n | Procedure | Conversion, n to multiport or thoracotomy | Duration of operation, min | Estimated bleeding, mL | Chest tube drainage or hospital stay, d | Major complications |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Kestenholz, 2006 [ | 14 | 20–64 | 13/1 | 6/8 | 10/3; 1 from right renal artery | MVATS | 1 (7.1%) | 133 (45–270) | 200 (20–1200) | 7.5 (3–13) | 3 pneumonia, 1 hemothorax |
| Tsang, 2006 [ | 6 | 27–64 | 6/0 | 4/2 | 6/0 | MVATS | 0 | 112.8 (90–140) | 283.3(100–500) | 3.2 | 1 wound infection |
| Shen, 2013 [ | 25 | 16–62 | 25/0 | 16/9 | 21/2; 1 phrenic artery; 1 intercostal artery | MVATS | 0 | 114.2 ± 31.2 | 228 ± 96.5 | 3.2 ± 1.4 | 0 |
| Liu, 2013 [ | 18 | 15–61 | 16/2 | 14/4 | 15/3 | MVATS | 0 | 133.1 ± 42.3 | 186.1 ± 279.4 | 2.7 ± 0.8 | 1 pneumonia |
| Lin, 2016 [ | 26 | 14–68 | 26/0 | 21/5 | 22/3; 1 celiac trunk | MVATS | 0 | 115.0 ± 30.4 | 65.0 ± 47.9 | 3.7 ± 1.3 | 1 bloody sputum |
| Wang, 2016 [ | 16 | 34.2 ± 14.0 | 16/0 | 13/3 | 14/2 | MVATS | 3 (18.8%) | 122 ± 40 | 116 ± 90 | 5.9 ± 1.4 | 1 intractable air leakage |
| Lin, 2018 [ | 19 | 17–62 | 17/2 | 14/5 | 17/2 | 7UVATS, 12MVATS | 0 | (151.6 ± 43.9) vs. (173.5 ± 63.1) | (64.3 ± 62.7) vs. (87.5 ± 102.5) | (3.0 ± 1.9) vs. (4.0 ± 2.7) | 1 air leakage, 1 chylothorax |
| Li, 2018 [ | 42 | 42.6 ± 11.5 | 42/0 | 32/10 | 35/7 | 1–2/3–4 ports VATS | 2 (4.8%) | 154 ± 52 | 193 ± 238 | 3.9 ± 1.5 | 1 reoperation, 3 transfusion |
| Li, 2019 [ | 33 | 23–55 | 33/0 | 19/14 | 24/8; 1 intercostal artery | 19UVATS, 14MVATS | 0 | (123.5 ± 27.3) versus (128.4 ± 18.5) | 100 (70–150) versus 145 (120–185) | 3 (2–3) versus 3.5 (3–4) | 4 chest pain/cough/hemoptysis |
| Wang, 2019 [ | 35 | 16–76 | 29/6 | 28/7 | 29/4; 1 subclavian artery; 1 other | MVATS | 0 | 150 (75–300) | 50 (10–600) | 3 (1–10) | 1 hoarseness |
| Li, 2020 [ | 67 | 15–71 | 65/2 | 48/19 | 57/10 | 21 UVATS, 46 MVATS | 6 (9.0%) | 126 (95–170) | 100 (50–150) | 4.1 ± 1.5 | 5 (7.5%) |
| Sun, 2020 [ | 24 | 18–65 | 21/3 | 20/4 | 20/3; 1 other | UVATS | 0 | 102 (55–150) | 90 (10–300) | 4 (1–10) | 1pneumothorax |
| Bishnoi, 2021 [ | 25 | 16–28 | 25/0 | 15/10 | 18/5; 2 others | NA | 1 (4.0%) | 179 | 204 | 3 | 1 reoperation, 1 air leakage |
| Summary | 350 | 14–76 | 334 (95.4%)/16 (4.6%) | 250 (71.4%)/100 (28.6%) | 288 (82.3%)/52 (14.9%); 10 others (2.8%) | – | 13 (3.7%) | Mean, < 180 | Mean, < 300 | 1–13 | 26 (7.4%) |
ILS intralobar pulmonary sequestration, ELS extralobar pulmonary sequestration, LLL left lower lobe, RLL right lower lobe, UVATS uniportal video-assisted thoracoscopic surgery, MVATS multiport video-assisted thoracoscopic surgery, NA not available